JP2025510666A5 - - Google Patents
Info
- Publication number
- JP2025510666A5 JP2025510666A5 JP2024555281A JP2024555281A JP2025510666A5 JP 2025510666 A5 JP2025510666 A5 JP 2025510666A5 JP 2024555281 A JP2024555281 A JP 2024555281A JP 2024555281 A JP2024555281 A JP 2024555281A JP 2025510666 A5 JP2025510666 A5 JP 2025510666A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- compound
- compound according
- alkyl group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263321440P | 2022-03-18 | 2022-03-18 | |
| US63/321,440 | 2022-03-18 | ||
| US202263347835P | 2022-06-01 | 2022-06-01 | |
| US63/347,835 | 2022-06-01 | ||
| PCT/CA2022/051266 WO2023173197A1 (en) | 2022-03-18 | 2022-08-22 | C4-carbonothioate-substituted tryptamine derivatives and methods of using |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510666A JP2025510666A (ja) | 2025-04-15 |
| JP2025510666A5 true JP2025510666A5 (enExample) | 2025-08-26 |
Family
ID=93294636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024555281A Pending JP2025510666A (ja) | 2022-03-18 | 2022-08-22 | Ｃ４－カルボノチオエート置換トリプタミン誘導体および利用法関連する出願 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250206701A1 (enExample) |
| EP (1) | EP4493542A4 (enExample) |
| JP (1) | JP2025510666A (enExample) |
| AU (1) | AU2022447256A1 (enExample) |
| CA (1) | CA3246231A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4174016B2 (ja) * | 2003-07-11 | 2008-10-29 | 株式会社ビーエル | 競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット |
| US8349898B2 (en) * | 2008-11-18 | 2013-01-08 | Wisconsin Alumni Research Foundation | Sigma-1 receptor ligands and methods of use |
| US12590065B2 (en) * | 2017-04-14 | 2026-03-31 | Zevra Therapeutics, Inc. | Levorphanol prodrugs and processes for making and using them |
| US12616706B2 (en) * | 2019-03-07 | 2026-05-05 | Arbormentis LLC | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations |
| DK4172145T3 (da) * | 2020-06-30 | 2026-07-20 | Reunion Neuroscience Inc | Tryptamin-prodrugs som serotonin-receptor-aktivatorer til behandling af f.eks. depression |
| AU2021328726A1 (en) * | 2020-08-21 | 2023-03-02 | Compass Pathfinder Limited | Novel psilocin derivatives having prodrug properties |
-
2022
- 2022-08-22 AU AU2022447256A patent/AU2022447256A1/en active Pending
- 2022-08-22 US US18/848,351 patent/US20250206701A1/en active Pending
- 2022-08-22 JP JP2024555281A patent/JP2025510666A/ja active Pending
- 2022-08-22 CA CA3246231A patent/CA3246231A1/en active Pending
- 2022-08-22 EP EP22931275.6A patent/EP4493542A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512301A5 (enExample) | ||
| JP7242681B2 (ja) | 選択的ｐ２ｘ３修飾薬 | |
| JP2024050527A5 (enExample) | ||
| CA2055859A1 (fr) | Derives d'oxazolopyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| JP2014510774A5 (enExample) | ||
| EP0876350A1 (fr) | Derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| RU2476429C2 (ru) | Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого | |
| TW200526567A (en) | Prostaglandin derivatives | |
| JP2019518050A5 (enExample) | ||
| JP2005525369A5 (enExample) | ||
| CN107249593A (zh) | 调节染色质结构的组合物用于移植物抗宿主疾病(gvhd)的用途 | |
| JP2012522759A5 (enExample) | ||
| MC1915A1 (fr) | Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant | |
| JP2025515833A5 (enExample) | ||
| CN102105146A (zh) | 用于治疗与暴露于烷化物质有关的损伤的方法 | |
| FR2934593A1 (fr) | Derives dimeriques d'artemisinine et application en therapie anticancereuse | |
| TW201139421A (en) | Novel ep4 agonist | |
| KR100979077B1 (ko) | 벤즈아제핀 화합물의 고체 염 및 이를 포함하는 약제학적 조성물 | |
| JP2005516035A5 (enExample) | ||
| CN1295560A (zh) | 用作药物的c11肟基和羟氨基前列腺素 | |
| WO2018101329A1 (ja) | 新規エステル体化合物並びにそれを用いたＰｉｎ１阻害剤、炎症性疾患治療剤及び大腸癌治療剤 | |
| LV10712B (en) | 2-ciano-3-hydroxypropene amides | |
| CN1137267A (zh) | 用作螯合剂的n，n′-二(2-羟基苄基)-乙二胺n，n′-二乙酸衍生物 | |
| JP2007519640A5 (enExample) | ||
| TWI666214B (zh) | 雙亞硝基鐵錯合物、包含該錯合物之藥學組合物或複合材料及其用途 |